Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Trinity Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Trinity Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 383 · Grade C

Trinity Meds

Visit Trinity Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 59 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Trinity Meds a bad call — it's best for people considering a bundled telehealth program who confirm the actual medication and full-term payment before accepting its final-sale policy. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
67
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
75
Track Record
88
63
CoreAge RxBrief Score 94 · 59Trinity Meds

Price, coverage & the tracker

CoreAge RxTrinity Meds
Brief Score94/100 (A)59/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Named medication and full quote unconfirmed

Advertised GLP-1 $99/mo or GLP-1/GIP $149/mo; exact named prescription, supply, full-term payment and required clinical services need confirmation.

Payments final at purchase, including unused/unshipped multi-month portions. Cancel at least 72 hours before billing; medical-disqualification refund deducts already used services.

Full price details

Current named semaglutide prescription and complete selected-plan quote unknown; program advertises GLP-1 $99/month or GLP-1/GIP $149/month without molecule-specific dose or supply confirmation

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Named medication and full quote unconfirmed

Advertised GLP-1 $99/mo or GLP-1/GIP $149/mo; exact named prescription, supply, full-term payment and required clinical services need confirmation.

Payments final at purchase, including unused/unshipped multi-month portions. Cancel at least 72 hours before billing; medical-disqualification refund deducts already used services.

Full price details

Current named tirzepatide prescription and complete selected-plan quote unknown; program advertises GLP-1 $99/month or GLP-1/GIP $149/month without molecule-specific dose or supply confirmation

CoverageUS only; restrictions by state, confirmed at intakeTerms say all 50 states plus Washington DC, subject to independent clinician and pharmacy eligibility for the patient location
Brand-name accessNot confirmedThe current class-level compounded program does not establish a named branded GLP-1 offer or an individual prescription preparation.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Trinity Meds: Class-level GLP-1 $99/GLP-1-GIP $149; named medication and complete quote unconfirmed. Payments final at purchase; cancel 72 hours before renewal. Medical-disqualification refund deducts used services.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.